Ocean Biomedical Statistics
Total Valuation
OCEA has a market cap or net worth of $33.96 million. The enterprise value is $51.77 million.
Important Dates
The next estimated earnings date is Tuesday, September 24, 2024, before market open.
| Earnings Date | Sep 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OCEA has 34.65 million shares outstanding. The number of shares has decreased by -11.08% in one year.
| Shares Outstanding | 34.65M |
| Shares Change (YoY) | -11.08% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 4.62% |
| Owned by Institutions (%) | 8.24% |
| Float | 3.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -681.99% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.95M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.56% in the last 52 weeks. The beta is 1.54, so OCEA's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -76.56% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 42.71 |
| Average Volume (20 Days) | 61,128 |
Short Selling Information
The latest short interest is 160,622, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 160,622 |
| Short Previous Month | 213,810 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 4.30% |
| Short Ratio (days to cover) | 1.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -98.59M |
| Net Income | -98.59M |
| EBITDA | n/a |
| EBIT | -11.81M |
| Earnings Per Share (EPS) | -$5.07 |
Full Income StatementBalance Sheet
The company has $31,000 in cash and $17.16 million in debt, giving a net cash position of -$17.13 million or -$0.49 per share.
| Cash & Cash Equivalents | 31,000 |
| Total Debt | 17.16M |
| Net Cash | -17.13M |
| Net Cash Per Share | -$0.49 |
| Equity (Book Value) | -75.22M |
| Book Value Per Share | -2.21 |
| Working Capital | -29.82M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.60M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.60M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |